Latest news
Control Bionics (ASX:CBL) Advances Global Regulatory Strategy With NeuroStrip FDA Listing - KalkineKalkine · Tue, 04 Aug 2026 01:27:00 GMTLumos Diagnostics (ASX:LDX) Secures US$767,800 FebriDx® Order from PHASE Scientific - KalkineKalkine · Tue, 04 Aug 2026 01:12:00 GMTWhy Is Teleflex (NYSE:TFX) in Focus After FDA Approval? - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 16:42:00 GMTMedline Inc. (MDLN) Under Securities Probe Following FDA Warning and 7% Stock Decline - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 15:30:00 GMTCeretas (ASX:CTS) Brings Alzheimer’s Ultrasound Venture to the ASX After A$8m IPO—Can Clinical Progress Drive Long-Term Value? - KalkineKalkine · Tue, 28 Jul 2026 13:10:00 GMT